MicroPort CardioFlow Medtech Corporation (2160.HK)
2160.HK Stock Price Chart
Explore MicroPort CardioFlow Medtech Corporation interactive price chart. Choose custom timeframes to analyze 2160.HK price movements and trends.
2160.HK Company Profile
Discover essential business fundamentals and corporate details for MicroPort CardioFlow Medtech Corporation (2160.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
4 Feb 2021
Employees
430.00
CEO
Luying Yan
Description
MicroPort CardioFlow Medtech Corporation, a medical device company, researches, develops, and commercializes transcatheter and surgical solutions for structural heart diseases in the People's Republic of China. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set to target aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China.
2160.HK Financial Timeline
Browse a chronological timeline of MicroPort CardioFlow Medtech Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 25 Mar 2026
Earnings released on 28 Aug 2025
EPS came in at -$0.10 , while revenue for the quarter reached $250.84M .
Earnings released on 27 Mar 2025
EPS came in at $0.00 , while revenue for the quarter reached $147.26M .
Earnings released on 28 Aug 2024
EPS came in at -$0.03 , while revenue for the quarter reached $239.63M .
Earnings released on 27 Mar 2024
EPS came in at -$0.14 , while revenue for the quarter reached $176.84M , missing expectations by -64.05%.
Earnings released on 29 Aug 2023
EPS came in at -$0.08 , while revenue for the quarter reached $190.81M .
Earnings released on 30 Mar 2023
EPS came in at -$0.16 , while revenue for the quarter reached $143.78M , missing expectations by -63.17%.
Earnings released on 29 Aug 2022
EPS came in at -$0.06 , while revenue for the quarter reached $146.08M .
Earnings released on 31 Dec 2021
EPS came in at -$0.06 , while revenue for the quarter reached $140.34M .
Earnings released on 30 Jun 2021
EPS came in at -$0.04 , while revenue for the quarter reached $103.49M .
Earnings released on 31 Dec 2020
EPS came in at -$0.19 , while revenue for the quarter reached $77.28M .
2160.HK Stock Performance
Access detailed 2160.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.